Results 101 to 110 of about 5,727,475 (289)

On identifying causal effects

open access: yes, 2010
A variety of questions in causal inference can be represented as probability distributions over hypothetical worlds where idealized randomized experiments known as interventions have taken place.
Tian, Jin, Shpitser, Ilya
core   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

SGL vs Lasso: comparison of power to detect 5 causal SNPs.

open access: yes, 2013
Each data point represents mean power over 500 MC simulations. Left: Causal SNPs drawn from single causal pathway. Right: Causal SNPs drawn at random.
Tien-Yin Wong (159436)   +7 more
core   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

A Cause Analysis Model of Nuclear Accidents in Marine Nuclear Power Plants Based on the Perspective of a Socio-Technical System

open access: yesSafety
Marine nuclear power plants (MNPPs) represent items of forward-looking high-end engineering equipment combining nuclear power and ocean engineering, with unique advantages and broad application prospects.
Fang Zhao   +3 more
doaj   +1 more source

Causal webs in epidemiology [PDF]

open access: yes, 2009
The notion of ‘causal web’ emerged in the epidemiological literature in the early Sixties and had to wait until the Nineties for a thorough critical appraisal. Famously, Nancy Krieger argued that such a notion isn’t helpful unless we specify what kind of
Russo, Federica, Federica Russo
core  

Simulation-Based Power Comparisons (10 rare causal variants).

open access: yes, 2014
The figure shows the empirical power at . Top panel: clustered causal variants; bottom panel: non-clustered causal variants. The letters “p” and “r” denote the numbers of protective variants and deleterious (or, risky) variants, respectively.
Wan-Yu Lin (91498)
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy